Evidence for the neuronal origin of immunoreactive interleukin-1 beta released by rat hypothalamic explants

G Tringali1, C Mancuso, A Mirtella

  • 1Institute of Pharmacology, Catholic University Medical School, Rome, Italy.

Neuroscience Letters
|November 29, 1996
PubMed

Insights

Rat hypothalamic explants release interleukin-1 beta (IL-1 beta). Potassium and noradrenaline stimulate this release, which is blocked by specific ion channel inhibitors, suggesting a neuronal origin for IL-1 beta.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Interleukin-1 beta (IL-1 beta) is a key inflammatory cytokine.
  • The hypothalamus plays a crucial role in regulating physiological processes.
  • Neuronal release of IL-1 beta is not fully understood.

Purpose of the Study:

  • To investigate the release of immunoreactive IL-1 beta (irIL-1 beta) from rat hypothalamus in vitro.
  • To determine the mechanisms regulating irIL-1 beta release.

Main Methods:

  • Tissue explant culture of rat hypothalamus.
  • Stimulation with high potassium (KCl) and noradrenaline.
  • Inhibition studies using specific ion channel blockers (omega-conotoxin, verapamil, nifedipine, tetrodotoxin, lidocaine) and receptor antagonists (propranolol, phentolamine).

Main Results:

  • Rat hypothalamic explants release significant amounts of irIL-1 beta.
  • K(+)-induced release is dependent on N-type calcium and Na+ channels.
  • Noradrenaline enhances irIL-1 beta release via beta-adrenergic receptors.
  • Involvement of verapamil and propranolol suggests a role for calcium and beta-adrenergic signaling.

Conclusions:

  • Hypothalamic irIL-1 beta release is stimulated by depolarization and noradrenaline.
  • The release mechanism involves voltage-gated calcium and sodium channels.
  • Evidence strongly suggests that irIL-1 beta released from hypothalamic explants is of neuronal origin.

Related Concept Videos